Abstract
This review discusses the mineral bone disorders in patients with chronic kidney disease. We focus on the management of these conditions by administration of calcium, vitamin D (ergocalciferol and cholecalciferol), vitamin D receptor activators (calcitriol, alphacalcidiol), phosphate binders and calcimimetics (cinacalcet).
Translated title of the contribution | Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover |
---|---|
Original language | Danish |
Journal | Ugeskrift for Laeger |
Volume | 174 |
Issue number | 47 |
Pages (from-to) | 2931-4 |
Number of pages | 4 |
ISSN | 0041-5782 |
Publication status | Published - 2012 |